February 27, 2018 / 9:22 PM / 3 months ago

BRIEF-Jazz Pharmaceuticals Q4 GAAP Earnings Per Share $3.79

Feb 27 (Reuters) - Jazz Pharmaceuticals Plc:

* JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2017 FINANCIAL RESULTS

* Q4 GAAP EARNINGS PER SHARE $3.79

* SEES ‍FULL YEAR 2018 REVENUES $1,860 MILLION -$1,930 MILLION ​

* SEES ‍FULL YEAR 2018 TOTAL NET PRODUCT SALES $1,845 MILLION -$1,910 MILLION ​

* SEES ‍FULL YEAR 2018 GAAP NET INCOME PER DILUTED SHARE $7.15-$8.45​

* SEES ‍FULL YEAR 2018 NON-GAAP ADJUSTED NET INCOME PER DILUTED SHARE $12.65-$13.25​

* QTRLY ‍TOTAL REVENUES $436.4 MILLION VERSUS $ 396.6 MILLION ​

* Q4 EARNINGS PER SHARE VIEW $2.98, REVENUE VIEW $441.3 MILLION — THOMSON REUTERS I/B/E/S

* FY2018 EARNINGS PER SHARE VIEW $13.07, REVENUE VIEW $1.85 BILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below